Orion Oyj
Search documents
Orion Oyj 2025 Q3 - Results - Earnings Call Presentation (OTCMKTS:ORINF) 2025-10-28
Seeking Alpha· 2025-10-28 12:01
Core Insights - The article discusses the importance of enabling Javascript and cookies in browsers to prevent access issues [1] Group 1 - The article emphasizes that users may be blocked from proceeding if an ad-blocker is enabled [1]
明晟公司MSCI北欧国家指数微幅上涨,报363.69点,北欧医疗保健板块领跑。中枢神经系统障碍、心血管疾病、泌尿障碍等疗法供应商Orion Oyj赫尔辛基股价涨4.1%,领跑一众成分股。这家芬兰公司宣布,其合作伙伴MSD已经将Opevesostat临床开发项目扩大至包括(一系列)女性癌症。
news flash· 2025-05-21 15:41
Core Viewpoint - MSCI Nordic Countries Index experienced a slight increase, closing at 363.69 points, with the healthcare sector leading the gains [1] Group 1: Company Performance - Orion Oyj, a supplier of therapies for central nervous system disorders, cardiovascular diseases, and urological disorders, saw its Helsinki stock price rise by 4.1%, outperforming other constituents [1] - The Finnish company announced that its partner MSD has expanded the clinical development project for Opevesostat to include a range of female cancers [1]